13389-05-4 Usage
Classification
Purine nucleoside analog
Antineoplastic Activity
Potential antineoplastic activity as a synthetic purine nucleoside analogue.
Mechanism of Action
Potent inhibitor of adenosine deaminase, inhibits DNA synthesis and repair.
Target
Interferes with the biological activities of extracellular adenosine and deoxyadenosine in cancer cells.
Investigation
Being investigated for therapeutic potential in various cancers, including chronic lymphocytic leukemia, non-Hodgkin lymphoma, and solid tumors.
Check Digit Verification of cas no
The CAS Registry Mumber 13389-05-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,8 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13389-05:
(7*1)+(6*3)+(5*3)+(4*8)+(3*9)+(2*0)+(1*5)=104
104 % 10 = 4
So 13389-05-4 is a valid CAS Registry Number.
13389-05-4Relevant articles and documents
ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK
-
Paragraph 0157; 0158; 0159; 0190, (2018/08/12)
Provided are a kind of nucleoside analogue compounds, and compositions comprising these compounds and pentostatin, their use for modulating circadian rhythm, preferably, for shifting circadian phase, and methods for modulating circadian rhythm, preferably, for shifting circadian phase via these compounds or the compositions.
